| Name | Publix Pharmacy #0410 |
|---|---|
| Organization Name | Publix Super Markets, Inc |
| Location | 7101 Radio Rd, Naples, Florida 34104 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (941) 455-5526 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A group of scientists from the Institute of Ecology and the Faculty of Medicine of the National University of Mexico, created a membrane capable of simultaneously detecting numerous organisms in the water or food that cause diarrhea and intestinal problems. This health problem annually kills 760 000 children under the age of five, according to the World Health Organization.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
The U.S. Senate last night approved the FY2008 Labor, HHS, and Education Appropriations Bill (S.1710), including a provision that directs the National Institutes of Health (NIH) to strengthen its Public Access Policy by requiring rather than requesting participation by researchers.
Cytochroma today announced the publication of new data from studies in a preclinical model indicating that chronic kidney disease is associated with markedly increased expression of the vitamin D catabolic enzyme, CYP24, which contributes to vitamin D insufficiency and resistance to vitamin D therapy. Parallel analysis of kidney biopsies obtained from CKD patients confirmed abnormal CYP24 expression in human disease as well.
Blue Cross Blue Shield of Delaware (BCBSD) announced today that it has signed an affiliation agreement with Pennsylvania-based Highmark Inc. (Highmark) that will position BCBSD to remain a strong local leader in the health care marketplace. This announcement is the culmination of a four-year corporate strategic planning process for BCBSD.
› Verified 4 days ago
| NPI Number | 1194765040 |
| Organization Name | PUBLIX SUPER MARKETS INC |
| Doing Business As | PUBLIX PHARMACY #0410 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 7101 Radio Rd, Naples, FL 34104 |
| Phone Number | 239-455-5526 |
News Archive
A group of scientists from the Institute of Ecology and the Faculty of Medicine of the National University of Mexico, created a membrane capable of simultaneously detecting numerous organisms in the water or food that cause diarrhea and intestinal problems. This health problem annually kills 760 000 children under the age of five, according to the World Health Organization.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
The U.S. Senate last night approved the FY2008 Labor, HHS, and Education Appropriations Bill (S.1710), including a provision that directs the National Institutes of Health (NIH) to strengthen its Public Access Policy by requiring rather than requesting participation by researchers.
Cytochroma today announced the publication of new data from studies in a preclinical model indicating that chronic kidney disease is associated with markedly increased expression of the vitamin D catabolic enzyme, CYP24, which contributes to vitamin D insufficiency and resistance to vitamin D therapy. Parallel analysis of kidney biopsies obtained from CKD patients confirmed abnormal CYP24 expression in human disease as well.
Blue Cross Blue Shield of Delaware (BCBSD) announced today that it has signed an affiliation agreement with Pennsylvania-based Highmark Inc. (Highmark) that will position BCBSD to remain a strong local leader in the health care marketplace. This announcement is the culmination of a four-year corporate strategic planning process for BCBSD.
› Verified 4 days ago
News Archive
A group of scientists from the Institute of Ecology and the Faculty of Medicine of the National University of Mexico, created a membrane capable of simultaneously detecting numerous organisms in the water or food that cause diarrhea and intestinal problems. This health problem annually kills 760 000 children under the age of five, according to the World Health Organization.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
The U.S. Senate last night approved the FY2008 Labor, HHS, and Education Appropriations Bill (S.1710), including a provision that directs the National Institutes of Health (NIH) to strengthen its Public Access Policy by requiring rather than requesting participation by researchers.
Cytochroma today announced the publication of new data from studies in a preclinical model indicating that chronic kidney disease is associated with markedly increased expression of the vitamin D catabolic enzyme, CYP24, which contributes to vitamin D insufficiency and resistance to vitamin D therapy. Parallel analysis of kidney biopsies obtained from CKD patients confirmed abnormal CYP24 expression in human disease as well.
Blue Cross Blue Shield of Delaware (BCBSD) announced today that it has signed an affiliation agreement with Pennsylvania-based Highmark Inc. (Highmark) that will position BCBSD to remain a strong local leader in the health care marketplace. This announcement is the culmination of a four-year corporate strategic planning process for BCBSD.
› Verified 4 days ago
Cvs Pharmacy # 03677 Type: Pharmacy Location: 2344 Immokalee Rd, Naples, Florida 34110 Phone: (239) 597-1600 | |
Cvs Pharmacy #01816 Type: Pharmacy Location: 5296 Tamiami Trl N, Naples, Florida 34103 Phone: (239) 261-6444 | |
Cvs Pharmacy # 04228 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5070 Airport Rd N, Naples, Florida 34105 Phone: (239) 435-0007 | |
Cvs Pharmacy # 04227 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8863h Tamiami Trl N, Naples, Florida 34108 Phone: (239) 597-8129 | |
Cvs Pharmacy # 05041 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5585 Golden Gate Pkwy, Naples, Florida 34116 Phone: (239) 353-8770 |